References in periodicals archive ?
In short-term (4- and 6-week) placebo-controlled trials, there was no statistical difference in the incidence of discontinuation due to adverse events between patients treated with aripiprazole and placebo (7% and 9%, respectively) or incidence of extrapyramidal syndrome (6% vs.
In short-term (4- and 6-week) placebo-controlled trials, there was no difference in the incidence of discontinuation due to adverse events between patients treated with ABILIFY (7%) and placebo (9%) or incidence of extrapyramidal syndrome (6% vs.
The most frequent side effects reported by patients in advanced stages of PD who were treated with pramipexole and levodopa were postural hypotension, dyskinesias, extrapyramidal syndrome, insomnia, dizziness and hallucinations.
Full browser ?